PMA device
Trulign Toric Posterior Chamber Intraocular Lens
Bausch & Lomb, Inc. · Lens, Intraocular, Toric Optics (MJP, Class III) · First FDA decision May 20, 2013, newest Jun 2, 2015Cataract
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
1
Naming "Trulign"
MAUDE reports
207
Brand "Trulign", since 2015
PubMed studies
5
Mentioning "Trulign"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Trulign Toric Posterior Chamber Intraocular Lens
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- TRULIGN TORIC POSTERIOR CHAMBER INTRAOCULAR LENSPMA supplement
P030002-S034 · Decided Jun 2, 2015 · 62 days after receipt · Normal 180 Day Track No User Fee
Device type: LENS, INTRAOCULAR, TORIC OPTICS (MJP) · Ophthalmology
- TRULIGN TORIC POSTER CHAMBER INTRAOCULAR LENSPMA supplement
P030002-S028 · Decided Jun 27, 2014 · 374 days after receipt · Normal 180 Day Track No User Fee
Device type: LENS, INTRAOCULAR, TORIC OPTICS (MJP) · Ophthalmology
- TRULIGN TORIC POSTERIOR CHAMBER INTRAOCULAR LENSPMA supplement
P030002-S027 · Decided May 20, 2013 · 419 days after receipt · Panel Track
Device type: LENS, INTRAOCULAR, TORIC OPTICS (MJP) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Trulign", any status and sponsor, newest update first.
Bausch & Lomb IncorporatedNot on our public-company list
NCT02394379 · 600 participants (planned) · Start Mar 19, 2015 · Primary completion Aug 5, 2019
Device: Trulign™ Toric IOL · For: Cataract
Sites: Rochester, New York
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Trulign", and for the whole product code for context.
This brand
207 reports: 1 malfunction, 206 injury, 0 death
Whole product code MJP
7,937 reports: 3,518 malfunction, 4,419 injury, 0 death
Newest reports for this brand
0001313525-2023-70108 · Received Sep 8, 2023 · Event dated Apr 3, 2023
Device type: Lens, Intraocular, Toric Optics (MJP)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: Capsular Contracture; Blurred Vision; UGH (Uveitis Glaucoma Hyphema) Syndrome
0001313525-2023-70038 · Received Mar 23, 2023 · Event dated May 24, 2022
Device type: Lens, Intraocular, Toric Optics (MJP)
Device problem as coded: Unintended Movement
Patient problem as coded: Blurred Vision; Loss of Vision
- TRULIGNInjury
MW5115006 · Received Feb 16, 2023 · Event dated May 24, 2022 · 1 other device named on this report
Device type: Lens, Intraocular, Toric Optics (MJP)
Device problem as coded: Positioning Failure; Migration or Expulsion of Device
Patient problem as coded: Blurred Vision; Visual Impairment
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0445-2012 · Started Nov 14, 2011 · Posted by FDA Jan 11, 2012
Reason given: Bausch + Lomb voluntary initiated the recall due to a physician complaint of haze on the Crystalens AO which was visualized using an angled beam from a slit lamp during the post-operative examination.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Lens, Intraocular, Accommodative (NAA)
Published research
The most relevant PubMed records for "Trulign"[tiab]. The summary above synthesizes these.
- Benefits and barriers of accommodating intraocular lenses.
Pepose JS, Burke J, Qazi MA · Curr Opin Ophthalmol · 2017Review
- Visual and Refractive Outcomes of a Toric Presbyopia-Correcting Intraocular Lens.
Epitropoulos AT · J Ophthalmol · 2016
- Toric intraocular lens orientation and residual refractive astigmatism: an analysis.
Potvin R, Kramer BA, Hardten DR, et al. · Clin Ophthalmol · 2016
- Safety and effectiveness of a new toric presbyopia-correcting posterior chamber silicone intraocular lens.
Pepose JS, Hayashida J, Hovanesian J, et al. · J Cataract Refract Surg · 2015Multicenter Study, Randomized Controlled Trial
- Intracorneal ring segments followed by toric pseudoaccomodating IOL for treatment of patients with corneal ectasia and cataract.
Konda S, Ambati BK · Am J Ophthalmol Case Rep · 2020
Other devices of this type
Also filed under product code MJP.
- TECNIS Toric 1-Piece Intraocular Lenses (IOL)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
- Crystalens and Trulign Toric Intraocular Lenses (Iols)Bausch & Lomb, Inc. · PMA 2016
- enVista One-Piece Hydrophobic Acrylic Toric Intraocular Lens (Model MX60T)Bausch & Lomb, Inc. · PMA 2018
- Crystalens Accommodating Intraocular Lens & Trulign Toric Intraocular LensBausch & Lomb, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.